000 | 01958 a2200577 4500 | ||
---|---|---|---|
005 | 20250517200802.0 | ||
264 | 0 | _c20190528 | |
008 | 201905s 0 0 eng d | ||
022 | _a1865-8652 | ||
024 | 7 |
_a10.1007/s12325-018-0670-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZang, Shufei | |
245 | 0 | 0 |
_aHaptoglobin Genotype and VitaminĀ E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design. _h[electronic resource] |
260 |
_bAdvances in therapy _c02 2018 |
||
300 |
_a218-231 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBody Weights and Measures |
650 | 0 | 4 | _aChina |
650 | 0 | 4 |
_aCytokines _xdrug effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aElasticity Imaging Techniques |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHaptoglobins _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aLife Style |
650 | 0 | 4 | _aMobile Applications |
650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xdrug therapy |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aVitamin E _xtherapeutic use |
700 | 1 | _aChen, Jin | |
700 | 1 | _aSong, Yu | |
700 | 1 | _aBai, Lang | |
700 | 1 | _aChen, Jinjun | |
700 | 1 | _aChi, Xiaoling | |
700 | 1 | _aHe, Fangping | |
700 | 1 | _aSheng, Huiping | |
700 | 1 | _aWang, Jing | |
700 | 1 | _aXie, Shilong | |
700 | 1 | _aXie, Wen | |
700 | 1 | _aYang, Yongfeng | |
700 | 1 | _aZhang, Jing | |
700 | 1 | _aZheng, Minghua | |
700 | 1 | _aZou, Zhengsheng | |
700 | 1 | _aWang, Bingyuan | |
700 | 1 | _aShi, Junping | |
773 | 0 |
_tAdvances in therapy _gvol. 35 _gno. 2 _gp. 218-231 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-018-0670-8 _zAvailable from publisher's website |
999 |
_c28054521 _d28054521 |